Reliq Health Technologies Inc. (RQHTF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.92: the stock has moved about 8% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerReliq Health Technologies Inc. (RQHTF) trades at $0.01. Reliq Health Technologies Inc. is a Canadian health technology firm specializing in secure virtual care and telehealth solutions, primarily through its iUGO Care SaaS platform. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for RQHTF: RQHTF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RQHTF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
RQHTF: 1/2 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Reliq Health Technologies Inc. (RQHTF) Healthcare & Pipeline Overview
Reliq Health Technologies Inc. is a Canadian health technology firm delivering secure virtual care and telehealth solutions via its iUGO Care SaaS platform. Specializing in remote patient monitoring for complex conditions, the company addresses the growing demand for home-based medical attention, positioning itself within the evolving digital healthcare landscape.
What Is the Investment Thesis for RQHTF?
Reliq Health Technologies Inc. operates in the expanding telehealth and remote patient monitoring sector, driven by increasing demand for home-based care, particularly for chronic disease management. The company's iUGO Care SaaS platform offers a solution for complex conditions, evidenced by a gross margin of 62.0%, suggesting efficient service delivery before operating expenses. However, the company faces significant challenges, including a negative profit margin of -95.5% and an extremely small market capitalization, reported as $0.00B in financials, though an AI insight notes it at $2.63M, underscoring its micro-cap status. As an OTC Other listed company, RQHTF carries inherent risks related to liquidity and potential share price volatility. Key growth catalysts include the continued expansion of its iUGO Care platform adoption among healthcare providers and the broader market shift towards virtual care models. Value drivers depend on the company's ability to secure additional funding, scale its operations, and achieve profitability in a competitive environment, while effectively managing its limited employee base of 11.
Based on FMP financials and quantitative analysis
RQHTF Key Highlights
Market Capitalization: $0.00B, reflecting an extremely small market valuation.
- Profit Margin: -95.5%, indicating significant unprofitability in its current operational phase.
- Gross Margin: 62.0%, suggesting strong unit economics and efficiency in delivering its SaaS platform.
- Beta: 0.92, implying slightly less volatility compared to the broader market.
- Employees: 11, indicating a lean operational structure for a health technology firm.
Who Are RQHTF's Competitors?
RQHTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| VEEV Veeva Systems Inc. | $262.25 | +0.49% | $42.6B | 905-pillar |
| GEHC GE HealthCare Technologies Inc. | $64.24 | -1.43% | $29.0B | 595-pillar |
| BTSG BrightSpring Health Services, Inc. | $57.88 | -6.63% | $11.4B | 695-pillar |
| TEM Tempus AI, Inc. | $59.29 | +0.93% | $10.4B | 315-pillar |
| TXG 10x Genomics, Inc. | $68.59 | +3.33% | $8.71B | 395-pillar |
| HQY HealthEquity, Inc. | $95.70 | +1.22% | $8.00B | 905-pillar |
| MTHRY M3, Inc. | $5.40 | +2.86% | $7.20B | 519-signal |
| HNGE Hinge Health, Inc. | $90.02 | +1.99% | $6.97B | 905-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are RQHTF's Key Strengths?
Specializes in secure virtual care and telehealth solutions for complex conditions.
- Operates a scalable Software-as-a-Service (SaaS) platform (iUGO Care).
- Addresses the growing demand for remote patient monitoring and home-based care.
- Achieved a gross margin of 62.0%, indicating strong unit economics.
What Are RQHTF's Weaknesses?
Extremely small market capitalization ($0.00B reported, $2.63M in AI insight).
- Significant unprofitability with a profit margin of -95.5%.
- Trades on the OTC Other tier, implying higher risk and limited liquidity.
- Small employee base of 11, potentially limiting scalability and operational bandwidth.
What Could Drive RQHTF Stock Higher?
RQHTF catalyst: Expansion of the iUGO Care platform's features to include new chronic disease management modules, potentially attracting a broader client base.
- Increasing adoption rates of telehealth solutions by healthcare providers globally, driving demand for Reliq Health's SaaS platform.
- Announcement of new strategic partnerships with healthcare systems or technology integrators to expand market reach.
- Efforts to secure additional funding or investment to support operational scaling and market penetration.
What Are the Key Risks for RQHTF?
Financial-distress signal — its Altman Z-Score of -3.23 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant unprofitability, as evidenced by a -95.5% profit margin, posing a challenge to long-term financial viability without substantial revenue growth.
- High liquidity risk and potential share price volatility due to the company's OTC Other listing and extremely small market capitalization.
- Intense competition within the telehealth and remote patient monitoring sector from larger, better-funded companies.
- Challenges in securing sufficient capital to fund ongoing operations, product development, and market expansion efforts.
- Reliance on a small team of 11 employees, which may limit the company's capacity for rapid scaling and diversified operations.
What Are the Growth Opportunities for RQHTF?
- Expansion of iUGO Care Platform Adoption: The increasing acceptance and integration of telehealth services by healthcare providers present a significant growth opportunity for Reliq Health. As healthcare systems globally seek to enhance efficiency and patient access, the demand for robust SaaS platforms like iUGO Care is projected to grow. The global telehealth market size was valued at approximately $83.5 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of over 20% through 2030. Reliq Health can capitalize by expanding its client base among hospitals, clinics, and long-term care facilities, emphasizing the platform's ability to manage complex conditions and improve patient outcomes.
- Increasing Demand for Remote Patient Monitoring (RPM): The market for remote patient monitoring is experiencing substantial growth, driven by the rising incidence of chronic diseases such as diabetes, hypertension, and heart failure. RPM solutions allow for continuous data collection and proactive intervention, reducing hospital readmissions and improving quality of life. The global RPM market is anticipated to reach over $175 billion by 2027. Reliq Health's iUGO Care platform is directly aligned with this trend, offering secure and comprehensive tools for RPM, positioning the company to expand its service offerings and capture a larger share of this specialized market segment by demonstrating clear clinical and economic benefits.
- Focus on Chronic Disease Management: Reliq Health's specialization in chronic disease management through its virtual care platform offers a targeted growth pathway. The prevalence of chronic diseases continues to rise globally, creating an immense and ongoing need for effective, continuous management solutions outside of traditional clinical settings. The market for chronic disease management solutions is projected to exceed $300 billion by 2030. By continually enhancing the iUGO Care platform's capabilities for specific chronic conditions, such as integrating AI-driven insights or personalized care plans, Reliq Health can deepen its penetration into this critical healthcare segment and attract providers seeking specialized, high-value solutions.
- Geographic Market Expansion: While headquartered in Canada, the virtual nature of Reliq Health's SaaS platform allows for potential expansion into new geographic markets, particularly in regions with high demand for telehealth and remote patient monitoring services. The United States, with its large and complex healthcare system, represents a significant opportunity, as do other developed nations facing similar challenges of an aging population and chronic disease burden. Strategic partnerships with local healthcare organizations or distributors could facilitate entry into these markets. This expansion could significantly broaden the company's addressable market and revenue streams over the next 3-5 years, leveraging the scalability inherent in its SaaS model.
- Technological Advancements and Platform Enhancements: Continuous innovation and enhancement of the iUGO Care platform represent a crucial growth opportunity. Integrating advanced technologies such as artificial intelligence (AI) for predictive analytics, machine learning for personalized care recommendations, or enhanced interoperability with electronic health records (EHRs) can significantly increase the platform's value proposition. Such advancements could attract new clients by offering more sophisticated tools for patient management and data analysis. Investing in R&D to stay ahead of technological curves and meet evolving healthcare needs will be vital for sustaining competitive advantage and driving long-term growth, potentially over the next 2-4 years.
What Threats Does RQHTF Face?
- Intense competition from larger, more established healthcare technology firms.
- Challenges in securing adequate funding to support growth and operations.
- Regulatory changes in telehealth and data privacy could impact operations.
- High liquidity risk and potential share price volatility due to OTC Other listing.
What Are RQHTF's Competitive Advantages?
- Specialized focus on secure virtual care and telehealth for complex conditions.
- Proprietary iUGO Care SaaS platform designed for remote patient monitoring.
- Early mover advantage and established presence in a niche segment of the telehealth market.
- Potential for strong customer relationships and integration within client workflows due to SaaS model.
What Does RQHTF Do?
Reliq Health Technologies Inc. is a health technology firm headquartered in Hamilton, Canada, dedicated to developing and deploying secure virtual care and telehealth solutions within the healthcare sector. Established in 2005, the company initially operated under the name Moseda Technologies Inc. before undergoing a strategic rebranding in May 2016 to its current identity. Its core offering is the iUGO Care platform, delivered as a Software-as-a-Service (SaaS) model. This platform is specifically engineered to facilitate remote patient monitoring and management, allowing individuals with complex medical conditions to receive necessary medical attention and oversight directly from the comfort and convenience of their homes. The iUGO Care platform integrates various functionalities designed to support chronic disease management and post-acute care, aiming to improve patient outcomes while potentially reducing healthcare costs associated with traditional in-person care. By leveraging its SaaS model, Reliq Health provides a scalable solution that can be adopted by healthcare providers to extend their reach and offer continuous care, particularly to vulnerable populations or those in remote areas. The company's strategic focus on secure data handling and user-friendly interfaces positions it within the competitive, yet rapidly expanding, telehealth market, addressing the increasing global demand for accessible and efficient digital healthcare services.
What Products and Services Does RQHTF Offer?
- Develops secure virtual care and telehealth solutions for the healthcare sector.
- Offers the iUGO Care platform as a Software-as-a-Service (SaaS).
- Enables remote patient monitoring for individuals with complex medical conditions.
- Facilitates medical attention and oversight for patients in their homes.
- Focuses on chronic disease management and post-acute care.
- Provides tools for healthcare providers to deliver continuous care remotely.
- Aims to improve patient outcomes and potentially reduce healthcare costs.
How Does RQHTF Make Money?
- Software-as-a-Service (SaaS) subscription model for its iUGO Care platform.
- Generates revenue through recurring fees paid by healthcare providers for platform access and services.
- Provides secure virtual care and telehealth solutions, enabling remote patient monitoring.
- Focuses on a scalable model that can be adopted by various healthcare organizations.
What Industry Does RQHTF Operate In?
Reliq Health Technologies Inc. operates within the dynamic and rapidly expanding Medical - Healthcare Information Services industry, specifically targeting the telehealth and remote patient monitoring (RPM) segments. This sector is experiencing robust growth, fueled by an aging global population, the rising prevalence of chronic diseases, and technological advancements enabling more sophisticated home-based care. The COVID-19 pandemic significantly accelerated the adoption of virtual care solutions, establishing a lasting trend towards remote healthcare delivery. Reliq Health's iUGO Care platform positions it to capitalize on this shift by providing secure SaaS solutions for managing complex conditions. The competitive landscape is characterized by both established healthcare technology giants and numerous agile startups. Reliq Health differentiates itself through its specialized focus on chronic disease management and post-acute care, aiming to carve out market share by offering tailored, secure, and user-friendly virtual care tools. The overall market trend points towards integrated, patient-centric digital health ecosystems, where companies like Reliq Health play a crucial role in extending care beyond traditional clinical settings.
Who Are RQHTF's Key Customers?
- Healthcare providers, including hospitals, clinics, and long-term care facilities.
- Patients with complex medical conditions requiring ongoing monitoring and care.
- Individuals needing post-acute care management.
- Healthcare systems seeking to expand virtual care capabilities and improve patient access.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
Forward Outlook
Wall Street analysts project Reliq Health Technologies Inc. revenue of about $5.1M for fiscal 2026, with EPS near $-0.06.
Key Financial Metrics
Return on assets is -79.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -17.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.88 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -20.8%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Reliq Health Technologies Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -3.23 places it in the distress zone, a signal of elevated financial risk.
Company Profile
Reliq Health Technologies Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Hamilton, CA. The company is led by CEO Chris Shields. RQHTF has traded publicly since 2010.
RQHTF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specializes in secure virtual care and telehealth solutions for complex conditions.
- Operates a scalable Software-as-a-Service (SaaS) platform (iUGO Care).
- Addresses the growing demand for remote patient monitoring and home-based care.
- Achieved a gross margin of 62.0%, indicating strong unit economics.
Bear Case
- Extremely small market capitalization ($0.00B reported, $2.63M in AI insight).
- Significant unprofitability with a profit margin of -95.5%.
- Trades on the OTC Other tier, implying higher risk and limited liquidity.
- Small employee base of 11, potentially limiting scalability and operational bandwidth.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
RQHTF Latest News
-
Stocks That Hit 52-Week Highs On Wednesday
· Oct 23, 2019
RQHTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RQHTF.
Price Targets
Wall Street price target analysis for RQHTF.
RQHTF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RQHTF; grades run from A+ (80-100) to F (below 30).
Leadership: Chris Shields
CEO
Chris Shields serves as the CEO of Reliq Health Technologies Inc., leading a team of 11 employees in the health technology sector. His leadership is focused on advancing the company's secure virtual care and telehealth solutions.
Track Record: Under Chris Shields' leadership, Reliq Health Technologies Inc. has continued to develop and market its iUGO Care platform, focusing on remote patient monitoring for complex conditions. His tenure has seen the company maintain its strategic direction in the virtual care space since its rebranding in 2016. Managing a lean team, Shields is responsible for operational execution and strategic initiatives aimed at expanding the platform's reach and securing market share in the competitive telehealth industry.
RQHTF OTC Market Information
Reliq Health Technologies Inc. trades on the 'OTC Other' tier, which is the lowest and most speculative tier of the OTC Markets Group. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards regarding financial reporting, minimum share price, and corporate governance, 'OTC Other' companies have minimal disclosure requirements. This tier typically includes companies that do not meet the standards for OTCQX or OTCQB, or choose not to provide financial information to OTC Markets. This classification signifies a higher degree of risk and less transparency for investors compared to higher tiers or exchange-listed securities.
- OTC Tier: OTC Other
- Limited Public Information: The 'Unknown' disclosure status means investors have very limited access to current and comprehensive financial or operational information.
- High Volatility and Price Manipulation: Low trading volume and minimal oversight can lead to extreme price fluctuations and increased susceptibility to manipulation.
- Lack of Analyst Coverage: OTC Other stocks typically receive no analyst coverage, making independent research and valuation difficult for investors.
- Difficulty in Valuing Shares: Without consistent financial reporting and market depth, accurately valuing the company's shares becomes highly speculative.
- Limited Exit Opportunities: The illiquidity of the market may make it difficult for investors to sell their shares when desired, potentially at a loss.
- Verify the company's current financial statements and operational updates directly from their website or regulatory filings, if available.
- Assess the management team's experience and track record, looking for evidence of successful business execution.
- Research the competitive landscape and the company's market position within the telehealth industry.
- Investigate any pending litigation or regulatory actions that could impact the company's operations or financial health.
- Evaluate the company's funding status and ability to secure future capital for growth and operations.
- Understand the technology behind the iUGO Care platform and its competitive advantages.
- Analyze the historical trading volume and bid-ask spread to gauge liquidity risks.
- Established in 2005 (as Moseda Technologies Inc.) and rebranded in 2016, indicating a long operational history.
- Headquartered in Hamilton, Canada, suggesting a physical presence and operational base.
- Has a specific product, the iUGO Care platform, addressing a defined market need (virtual care for complex conditions).
- Operates in a legitimate and growing sector (health technology, telehealth).
Reliq Health Technologies Inc. Healthcare Stock: Key Questions Answered
Is RQHTF a good stock?
Stock Expert AI does not rate RQHTF buy, sell or hold. Reliq Health Technologies Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does Reliq Health Technologies Inc. do?
Reliq Health Technologies Inc. is a Canadian health technology company that develops and offers secure virtual care and telehealth solutions. Its primary product is the iUGO Care platform, delivered as a Software-as-a-Service (SaaS).
What are the key factors to evaluate for RQHTF?
Evaluate RQHTF on fundamentals, analyst consensus, and risk factors. Gross Margin: 62.0%, suggesting strong unit economics and efficiency in delivering its SaaS platform. Not financial advice.
How frequently does RQHTF data refresh on this page?
RQHTF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven RQHTF's recent stock price performance?
Reliq Health Technologies Inc. (RQHTF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specializes in secure virtual care and telehealth solutions for complex conditions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RQHTF overvalued or undervalued right now?
Reliq Health Technologies Inc. (RQHTF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of RQHTF?
Yes, most major brokerages offer fractional shares of Reliq Health Technologies Inc. (RQHTF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track RQHTF's earnings and financial reports?
Reliq Health Technologies Inc. (RQHTF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for RQHTF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Market capitalization discrepancy between 'FINANCIALS' ($0.00B) and 'AI INSIGHT' ($2.63M) was addressed by acknowledging both figures and prioritizing the direct 'FINANCIALS' data point for key metrics while using the AI insight's figure to elaborate on the concept of small market cap risk.